Claret Capital Partners’ Post

Bird & Bird is proud to have successfully advised Nexstim Plc, a Finnish, globally operating medical technology company, on its cooperation and investment agreements with Brainlab AG, a leading German developer of advanced medical technology solutions.   The cooperation agreement aims at the advancement of non-invasive brain mapping technologies, as well as the distribution of certain Nexstim products by Brainlab. As part of this partnership, Brainlab and Nexstim have also agreed on a maximum of EUR 5,095,000 equity investment into Nexstim.   Our core advisory team included Maria Carlsson, Laura Huomo, Iina-Mari Supperi, Vuokko Rajamäki, Dr. Juliana Kliesch, Marla Melin, and Rondy Stenman.    Congratulations to all parties involved! 👏 We look forward to the advancements ahead. #twobirdsnordics #medtech #investments

To everyone who was able to join LaunchWorks CDMO and PSG Life Sciences for today's webinar "Unlocking Investment: Strategies to Secure Scientific Support and Funding", a huge thank you! We hope you gained valuable insights on navigating the path to successful product launch. If you missed us today, stay tuned for the recording which will be available soon! #commercialization #lifesciences #research #diagnostics #therapeutics #investor #funding #developement #manufacturing #webinar

🔬 Dive into the future of healthcare with our outstanding lineup of German startups currently participating in our Life Sciences program! These innovative companies are on a mission to revolutionize diagnostics, medical devices, therapeutics, and biotech, and they're gearing up for international expansion into the U.S. market. Meet our talented cohort: Dermagnostix, fasciotens GmbH, IRUBIS, Makrolife Biotech, and VesselSens. The Life Sciences program supports these startups in understanding the market dynamics, refining their value proposition, and learning how to navigate product, clinical, regulatory, and commercial challenges. 🚀 With their sights set on the U.S., they are poised to make waves in the global healthcare landscape, so stay tuned! #LifeSciences #healthcare #GoFarGrowFast #internationalexpansion #biotech

🧠 INBRAIN Neuroelectronics secures $50m funding to advance its BCI technology New investors EIC Fund, Fond ICO Next Tech, CDTI-Innvierte and Avançsa, and existing investors Asabys Partners, Aliath Bioventures and Vsquared participated in the financing round. In addition to the Series B round, which brings its total investment to $68m, the company also secured additional funding and support from Germany-based Merck. The partnership aims to advance its technology platform for human use, across both central and peripheral nervous system applications, said the medical technology company. Read more online: https://lnkd.in/e5rYDKHZ 📰 Follow Medical Device Developments to receive the latest medical device news daily and to subscribe to our weekly newsletter #MedicalDeviceDevelopments #medicaldevices #medicalmanufacturing

𝗕𝗼𝘀𝘁𝗼𝗻 𝗦𝗰𝗶𝗲𝗻𝘁𝗶𝗳𝗶𝗰 𝗘𝘅𝗽𝗮𝗻𝗱𝘀 𝗣𝘂𝗹𝘀𝗲𝗱 𝗙𝗶𝗲𝗹𝗱 𝗔𝗯𝗹𝗮𝘁𝗶𝗼𝗻 𝗕𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝘄𝗶𝘁𝗵 𝗖𝗼𝗿𝘁𝗲𝘅 𝗔𝗰𝗾𝘂𝗶𝘀𝗶𝘁𝗶𝗼𝗻 Boston Scientific has announced its acquisition of Cortex, a company specializing in pulsed field ablation technology. This strategic move aims to enhance Boston Scientific's capabilities in the growing field of cardiac ablation, particularly for treating atrial fibrillation. 𝗞𝗲𝘆 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀 𝗦𝘁𝗿𝗲𝗻𝗴𝘁𝗵𝗲𝗻𝗶𝗻𝗴 𝗣𝗼𝗿𝘁𝗳𝗼𝗹𝗶𝗼: The acquisition will bolster Boston Scientific's position in the pulsed field ablation market, allowing for more innovative solutions in cardiac care. 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝘃𝗲 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆: Cortex advanced technology is expected to complement Boston Scientific's existing product offerings, enhancing treatment options for patients. 𝗠𝗮𝗿𝗸𝗲𝘁 𝗚𝗿𝗼𝘄𝘁𝗵: This acquisition aligns with the increasing demand for effective cardiac procedures, positioning Boston Scientific for future growth in the medical device industry. For more details, visit Fierce Biotech - https://lnkd.in/dkW8Txaj #BostonScientific #PulsedFieldAblation #CardiacCare #HealthcareInnovation #NIPER #NIPERM #DOMD #MedTech

Day 1 at the Bloom Burton conference! Great talks from Synaptive Medical, Microbix and Intellijoint Surgical Inc. about their technologies and growth plans. The keynote speech from Eli Casdin did not disappoint either. Eli is the CIO of Casdin Capital, LLC which exclusively invests in the life science sector. Here were some key takeaways he had for investors and industry: - this life science sector is unpredictable and volatile - investors are currently choosing big and safe over small and risky. This will likely change as the margins at the top slim down and investors will lean more into small and risky - the life science sector is important and maybe the most important vertical to invest in - a good management team is the key to a good company - early revenue is a great indicator of success #bloomburton

𝗙𝗼𝗿𝘄𝗮𝗿𝗱 𝗧𝗼𝘄𝗮𝗿𝗱 🚀 "𝗘𝗮𝗰𝗵 𝗻𝗲𝘄 𝘄𝗲𝗲𝗸 𝗶𝘀 𝗮 𝗻𝗲𝘄 𝗼𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝘆 𝗳𝗼𝗿 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻. 𝗟𝗲𝘁’𝘀 𝗰𝗼𝗻𝘁𝗶𝗻𝘂𝗲 𝗮𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝘁𝗼𝗴𝗲𝘁𝗵𝗲𝗿!" In clinical research, progress never takes a day off. Each Monday is a fresh start, a new chance to push boundaries, ask the right questions, and create a meaningful impact. Whether refining trial designs, managing complex global studies, or sourcing strategic R&D services, every innovation brings us closer to breakthroughs. From offering customized project solutions to conducting clinical evaluations for cutting-edge medical devices, diagnostics, and digital therapeutics, our work is all about making an impact. Let’s dive into this week with renewed energy and commitment to driving innovations that can transform lives! #ClinicalResearch #Innovation #NewWeekNewOpportunities

Download the latest edition of our Diagnostics and Tools BlueBook in an updated format! Discover a monthly executive review that captures the essence of valuation trends, M&A developments, and transactions in this evolving industry. Key highlights from the December 2024 edition include: 📌Navis Clinical Laboratories was acquired by Wildcat DX 📌Surgical Science announced its acquisition of Intelligent Ultrasound 📌Pleno closed a $25 Series A Financing, led by Deerfield Management, Foresite Capital, and Medical Excellence Capital Want to read more? Download using the link below: https://hubs.li/Q033v51B0 #InvestmentBanking #MergersAndAcquisitions #LifeSciences #PrivateEquity

Inspira™ expands HYLA™ technology into personalized Blood Lab Testing, revolutionizing real-time blood analysis for the rapid detection of life-threatening conditions within minutes! “Our plans to use HYLA to perform blood work without the need to take physical blood samples is part of a broader business strategy,” said Dagi Ben-Noon, CEO of Inspira Technologies. “The core technologies of the INSPIRA ART are progressing, with the Company currently performing a clinical evaluation of the HYLA blood technology at Sheba hospital, with results expected to be revealed in the near future.” Read more >> https://lnkd.in/d7dGBJkc #MedTech #LifeSupport #BloodAnalysis #TechStocks #Nasdaq #IINN

There's no denying it: Multicellular models offer huge potential in early drug discovery. They provide a more physiologically relevant environment that boosts success rates further down the development pipeline. The question today becomes, how can we make better use of them, with the (limited) resources that we have? Our very own Markus Gershater, along with the British Heart Foundation's Kavita R. and SPT Labtech's Maryia Karpiyevich, PhD, are on hand to talk solutions. Join them on June 26 at 11 am EDT / 8 am PDT / 4 pm BST to learn about how we can use advances in software and hardware automation in assay development to: – Offer more accurate predictability of new drug candidates – Leverage resources more efficiently through streamlined workflows and data-driven decision-making #DrugDiscovery #LabAutomation #LiquidHandling